The transcription factor EGR2 is the molecular linchpin connecting STAT6 activation to the late, stable epigenomic program of alternative macrophage polarization by Daniel, B. et al.
The transcription factor EGR2 is the
molecular linchpin connecting STAT6
activation to the late, stable epigenomic
program of alternative macrophage
polarization
Bence Daniel,1,2,3,11,12 Zsolt Czimmerer,4,12 Laszlo Halasz,1,2,3,12 Pal Boto,4 Zsuzsanna Kolostyak,4
Szilard Poliska,4 Wilhelm K. Berger,1,2,3 Petros Tzerpos,4 Gergely Nagy,4 Attila Horvath,4
György Hajas,5 Timea Cseh,4 Aniko Nagy,4 Sascha Sauer,6,7,8,9 Jean Francois-Deleuze,10
Istvan Szatmari,4 Attila Bacsi,5 and Laszlo Nagy1,2,3,4
1Department of Medicine, 2Department of Biological Chemistry, Johns Hopkins University School of Medicine, St. Petersburg,
Florida 33701, USA; 3Institute for Fundamental Biomedical Research, Johns Hopkins All Children’s Hospital, St. Petersburg,
Florida 33701, USA; 4Department of Biochemistry andMolecular Biology, Faculty of Medicine, University of Debrecen, Debrecen
4032, Hungary; 5Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen 4032, Hungary; 6Otto
Warburg Laboratory, Max Planck Institute for Molecular Genetics, Berlin 14195, Germany; 7CU Systems Medicine, University of
Würzburg, Würzburg 97070, Germany; 8Berlin Institute for Medical Systems Biology, 9Berlin Institute of Health, Max-Delbrück-
Center forMolecularMedicine, Berlin 13125,Germany; 10CentreNational deGénotypage, Institut deGénomique, Commissariat à
l’Énergie Atomique, Evry 91000, France
Macrophages polarize into functionally distinct subtypes while responding to microenvironmental cues. The
identity of proximal transcription factors (TFs) downstream from the polarization signals are known, but their ac-
tivity is typically transient, failing to explain the long-term, stable epigenomic programs developed. Here, we
mapped the early and late epigenomic changes of interleukin-4 (IL-4)-induced alternative macrophage polarization.
We identified the TF, early growth response 2 (EGR2), bridging the early transient and late stable gene expression
program of polarization. EGR2 is a direct target of IL-4-activated STAT6, having broad action indispensable for 77%
of the induced gene signature of alternative polarization, including its autoregulation and a robust, downstream TF
cascade involving PPARG. Mechanistically, EGR2 binding results in chromatin opening and the recruitment of
chromatin remodelers and RNA polymerase II. Egr2 induction is evolutionarily conserved during alternative po-
larization ofmouse and humanmacrophages. In the context of tissue residentmacrophages, Egr2 expression ismost
prominent in the lung of a variety of species. Thus, EGR2 is an example of an essential and evolutionarily conserved
broad acting factor, linking transient polarization signals to stable epigenomic and transcriptional changes in
macrophages.
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Macrophages (MFs) are integral parts of innate immunity
and represent the first line of defense against invading
pathogens. These activities require plasticity and rapid re-
sponses to environmental cues, leading to the deployment
of epigenomicmechanisms resulting in specific and stable
gene expression programs. MF gene expression is thought
to be regulated at three levels. The first level is a perma-
nent program established by the developmental regu-
lation and is maintained by lineage-determining
transcription factors (LDTFs) like PU.1, CEBP, and AP-1.
The second level is an adaptation to a givenmicroenviron-
ment brought about by distinct tissue-specific
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polarization signals (Amit et al. 2016; Guilliams et al.
2020) modulating TFs’ activity (Bonnardel et al. 2019);
i.e., singular polarizing cytokines such as IL-4 or IL-13
via signal transducer and activator of transcription 6
(STAT6). The third level of regulation takes place tran-
siently upon pathogen encounter or inflammatory stimu-
lation (Glass andNatoli 2016). Therefore,MF polarization
is part of normal physiologic processes, actively contribut-
ing to controlling infection, cancer, and inflammatory
disease progression (Lawrence and Natoli 2011). Conse-
quently, investigation of the polarization process became
an intensely researched topic in immunology with thera-
peutic ramifications.
The two end points of the contiguous spectrum of mac-
rophage polarization are the classical polarization of mac-
rophages (M1 MFs) via TLR or inflammatory cytokine
signaling such as interferon γ or at the opposite end of
the spectrum, alternative polarization (M2 MFs) induced
by IL-4 or IL-13 (Murray et al. 2014). These two models
are widely used to learn about the molecular events of
polarization of MFs (Murray et al. 2014). Functionally,
classically polarized MFs are characterized by high anti-
microbial activities critical for host defense, while alter-
natively polarized MFs exhibit a characteristically more
anti-inflammatory profile contributing to tissue-regenera-
tion, tissue-remodeling, and the resolution of inflamma-
tion (Shapouri-Moghaddam et al. 2018). The in vivo
roles of alternatively polarized MFs are highlighted in al-
veolar MFs in the steady-state and different pathological
conditions including asthma and allergies, parasite infec-
tion, fibrosis, and cancer (Gordon and Martinez 2010;
Cohen et al. 2018) . The cytokines IL-4 or IL-13 are the ini-
tiators of this stable gene expression program and cellular
phenotype in its purest form and phosphorylated STAT6
acts as a downstream immediate transcriptional regula-
tor. STAT6 is required for alternative polarization by IL-
4 in bone marrow-derived macrophages (BMDM) and in
vivo to mount effective antihelminth defense (Rückerl
and Allen 2014). However, the requirements and contri-
bution of myeloid or macrophage STAT6 are not as well
understood due to the lack of genetic evidence establish-
ing MF cell-autonomous function, as well as establishing
the contribution of the various aspects of Th2 immune
responses. Thus, BMDM represents the gold standard
model to study the epigenomic and molecular details of
polarization.
The TFs PU.1, AP-1, C/EBP, and IRF are all critical for
MF development and function, establishing the MF-spe-
cific regulatory element landscape (lineage identity)
(Heinz et al. 2015).Moreover, TF binding at low accessible
genomic regions (labeled regulatory regions) also contrib-
utes to lineage identity in macrophages (Horvath et al.
2019), and form amolecular landing strip for signal-depen-
dent transcription factors (SDTFs). These genomic loci are
readily used during the initiation of polarization and con-
fer plasticity. The early steps of alternative MF polariza-
tion have been studied, and the role of de novo/latent
enhancers, mediating new cellular functions as well as
providing cellular memory, has been established (Heinz
et al. 2015). This is triggered by STAT6 homodimers
that act in a rapid and transient fashion. DNA binding of
STAT6 alters the expression of hundreds of genes within
the first few hours of polarization, including several TFs.
Due to its transient mechanism of action, the majority
of STAT6 is released from the chromatin after 24 h of cy-
tokine exposure (Czimmerer et al. 2018). Therefore, the
polarization program enters into a self-sustained, largely
STAT6-independent stable state. This observation leads
to a so-far unresolved conundrum on how transiently act-
ing STAT6 induces a stable and sustained polarization
program.
Several STAT6-induced TFs have been described as es-
sential regulators of the alternative MF phenotype, in-
cluding the peroxisome proliferator-activated receptor γ
(PPARG) (Odegaard et al. 2007), KLF4 (Liao et al. 2011),
IRF4 (Satoh et al. 2010), MYC (Pello et al. 2012), and
more recently BHLHE40 (Jarjour et al. 2019). The latter
is reported to specifically control the proliferation of large
peritoneal MFs when IL-4 is abundant (Jarjour et al. 2019).
Our recent study suggests that the nuclear receptor
PPARG is a late regulator of the alternative polarization
program via ligand-regulated gene expression and tran-
scriptional memory. Importantly, neither of these TFs
possess widespread regulatory roles when MFs transit
from the early to late polarization state (Daniel et al.
2018a).
Although the listed TFs are induced by STAT6 and their
expression is sustained beyond STAT6’s presence, their
action is highly specific, controlling very confined parts
of the broad polarization program. Therefore, there is a
hiatus in our understanding, leading to the proposition
that broader epigenomic mechanism(s) and/or factor(s)
directly controlled by STAT6must exist, acting as molec-
ular linchpin(s) to link the early transient and late stable
molecular events of polarization.
We took an unbiased systematic approach in the search
for such epigenomic regulators, integrating both the map-
ping of genome activity patterns and de novo motif analy-
sis. Using the combination of P300 (general coactivator
with histone acetyltransferase activity) and H3K27ac
chromatin immunoprecipitation sequencing (ChIP-seq),
we defined the early and late genome activity patterns of
alternative polarization in BMDMs. Our analyses, which
included genetic gain and loss-of-function studies, identi-
fied the TF EGR2 acting as a molecular linchpin between
IL-4-activated STAT6 and a downstream stable transcrip-
tional network of polarization.
Results
Mapping the temporal genome activity patterns
of alternative MF polarization
In order to obtain robust and unbiased data sets tomap the
early transient and late stable events of alternative polar-
ization we generated a time course of epigenomic, cistro-
mic, and transcriptomic changes. We used murine bone
marrow-derived macrophages (BMDMs referred to as
MFs) and IL-4-mediated MF polarization as a model. Ma-
ture, unstimulated MFs received IL-4 for 1 h (short-term
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polarization) and 24 h (long-term polarization) to reveal
early and late genome activities. We devised an approach
that maps significant changes in P300 binding and its
correlation with H3K27ac levels (histone modification
correlating with P300 activity), using ChIP-seq to map ac-
tive enhancers (Creyghton et al. 2010).
First, we identified genomic regions with differential
P300 and H3K27ac levels followed by de novo motif dis-
covery in the underlying genomic regions. This approach
revealed the activated (n= 16,735) and repressed (n=
17,582) regulatory regions of polarization, while 14,353
sites showed no change (Fig. 1A; Supplemental Fig. S1A;
Supplemental Table S1). Clustering the activity patterns
of regulatory elements yielded three activated and three
repressed groups. Activated regulatory elements exhibited
“early transient” (activated at 1 h and lost activity by 24 h;
n= 9426), “early sustained” (activated at 1 h and retained
activity at 24 h; n = 2534), and “late” genomic activities
(activated only by 24 h; n = 4775). Repressed regulatory
elements followed very similar patterns by featuring
“transiently” repressed (repressed at 1 h, but relieved of re-
pression by 24 h; n= 12,496), “early” repressed (n= 1346)
and “late” repressed genome activity sites (n= 3740)





Figure 1. Regulatory elements with distinct temporal genome activity patterns identify and link the EGR motifs to late genome activ-
ities. (A) Read distribution plot of P300 binding in the three groups showing distinct genome activity pattern in control and IL-4 polarized
macrophage for the indicated periods of time. Results are represented in RPKM (reads per kilobase per million mapped reads) values. (B)
Read distribution plot of H3K27ac signal in the three induced genome activity pattern groups in control and IL-4 polarizedmacrophage for
the indicated periods of time. Signals are visualized around P300 summits. RPKM values are plotted. (C ) Average binding signal for P300
and H3K27ac are represented as box plots on the genomic regions showing induced genome activity patterns. Average log10 CPM (counts
permillionmapped reads) values are plotted. Significant changes are determined withWilcoxon test at P<0.05. (D) Genomic distribution
of the regulatory elements exhibiting distinct genome activity pattern. (E) Motif enrichment plots on the regulatory regions exhibiting
different genome activity patterns. For each motif logo, P-value and percentage of genomic regions that contain the given motif in the
target (P300-bound) and background genomic regions (in parenthesis) are shown. (F ) Box plot representation of STAT6 and EGR motif
scores on the induced genome activity pattern groups. Significant changes are determined withWilcoxon test at P<0.05. (G) Distribution
of the enriched STAT6 and EGRmotifs around the identified P300 summits are shown for the induced genome activity pattern groups in a
±200-bp window. Shaded areas represent the 95% confidence interval for LOESS smoothed means.
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regulatory elements exhibiting increased genome activi-
ties were located on intergenic and intronic regions with
marginal differences between the different categories
(Fig. 1D), while a significant portion (∼40%) of transiently
repressed genomic regions occurred at promoters (Supple-
mental Fig. S1C).These analyses uncovered the dynamics
of the epigenomic changes, cataloged the immediate early
and long-term, sustained genome activities of alternative
MF polarization and prompted us to seek the drivers of the
observed changes.
Late and sustained genome activity patterns associate
with the binding motif of the EGR transcription factor
family
In order to identify candidate TFs mediating differential
genome activity patterns, we turned our attention to the
sequence determinants of the genomic regions exhibiting
changes. Motif enrichment analysis identified the TFmo-
tifs associated with MF-specific regulatory regions across
the three different genome activity groups (e.g. PU-1, AP-
1, IRF, RUNX, and C/EBP) (Horvath et al. 2019). We could
confirm that genomic regions of early activation (“early
transient” and “early sustained”) were enriched for the
STAT6 TF-binding motif, the initiator of the polarization
process. Importantly, we observed the enrichment of nov-
el TF motifs that have not been linked to genome activa-
tion in this model and were largely specific to genomic
regions with sustained activity such as EGR and USF2
(Fig. 1E). Among these, EGR motifs were enriched specif-
ically in the “early sustained” and “late” genome activity
groups, indicating the potential importance of the respec-
tive TF family at these genomic regions (Fig. 1F,G). How-
ever, EGRmotifs were not revealed using the enrichment
analysis at repressed sites (Supplemental Fig. S1D), super-
visedmotif score analysis at “transiently” repressed geno-
mic regions uncovered similarly strong EGRmotifs to the
ones detected at “late” induced sites (Supplemental Fig.
S1E). Interestingly, “transiently” repressed regions exhib-
ited rapid loss of P300 and H3K27ac at 1 h but genome ac-
tivity returned to the basal level by 24 h (Supplemental
Fig. S1A). Altogether, this is indicative of EGR TFs being
transcriptional activators of the late polarization program
and may contribute to repression via indirect mecha-
nisms. Prompted by these results, we decided to embark
on evaluating the roles of EGRs in genome activation dur-
ing alternative macrophage polarization.
EGR2 is a direct IL-4/STAT6 target with an expansive
enhancer network
Our analyses thus identified an enrichment for the EGR
motif at polarization-induced regulatory regions and pre-
dicted roles for this TF family in the late molecular pro-
gram of polarization. The EGR TF family consists of
four members with homologous DNA-binding domains
(Poirier et al. 2007). Our most recent transcriptome-wide
studies demonstrated the induced expression of Egr2
along with the marker genes (Retnla, Chil3, and Arg1) of
alternative polarization (Czimmerer et al. 2018; Daniel
et al. 2018b). Importantly, other EGR family members
(Egr1, Egr3, and Egr4) were barely expressed and IL-4 had
no impact on their expression (Supplemental Fig. S2A).
The Egr2 transcript was below our detection limit in
unstimulated cells; however, it showed rapidly induced
and sustained mRNA levels in the presence of IL-4.
Thus, we took a closer look at the Egr2 locus utilizing
ChIP-seq data for P300, H3K27ac, STAT6, and RNAPII-
pS2 (elongating RNA polymerase II), which informed us
about the existence of an enhancer cluster of ∼23 putative
enhancer regions downstream from the gene and one
enhancer located upstream (E1) (Fig. 2A; Supplemental
Table S2). These putative enhancer regions contained
STAT6motifs (Fig. 2A) and exhibited slightly different ge-
nome activity patterns and STAT6 occupancies, with a
few of them showing “late,” while most of them showed
“early transient” and “early sustained” activities (pre-
sented in Figs. 1, 2A). Using Stat6−/− MFs we could dem-
onstrate that Egr2 is an IL-4 and Stat6-dependent gene
using a time-course experiment (1-, 3-, 6-, and 24-h-long
exposure) (Fig. 2B). Also, we selected four distant enhancer
regions (+61, +96, +157, and +175 kb) bound by STAT6 and
having increased P300, H3K27ac, and RNAPII signals af-
ter 1-h IL-4 stimulation for validation purposes. Enhancer
RNA synthesis, as a marker of enhancer activity, was rap-
idly induced at 1 h andmaintained the induced levels over
the time course in a strictly IL-4- and Stat6-dependent
manner (Fig. 2C). Thus, Egr2 is an immediate early target
of the IL-4/STAT6-activated transcriptional program and
harbors an elaborate STAT6-bound enhancer network
spanning almost 200 kb.
Polarization-induced EGR2 populates the macrophage
genome largely avoiding the STAT6 cistrome due to its
distinct temporal dynamics
The regulation and expression level of Egr2 are indicative
of robust and long-term regulatory roles during the polar-
ization process. In order to evaluate the protein levels and
IL-4-mediated induction, we carried out Western blot
analyses. EGR2 proteinwas not detectable in controlmac-
rophages, but IL-4 exposure led to robust induction (Fig.
2D; Supplemental Fig. S2B). Thus, we set out to generate
a genome-widemap of EGR2-bound genomic regions after
1 and 24 h of IL-4 polarization using ChIP-seq analysis (re-
ferred to as the EGR2 cistrome). We performed a compar-
ative analysis with the STAT6 cistrome in the same
experimental system using our published data sets (Czim-
merer et al. 2018). In unstimulated MFs, negligible
binding was detected for both STAT6 and EGR2 (Supple-
mental Fig. S2C,D). As we and others reported previously,
STAT6 rapidly populated the MF genome as early as 1 h
after IL-4 exposure (∼21,000 binding sites) (Ostuni et al.
2013; Czimmerer et al. 2018). EGR2 binding was also
measurable at this time point (∼10,000) binding sites), al-
though very low binding signals could be detected. After
24 h, the STAT6 cistrome diminished substantially, while
the EGR2 cistrome went through a remarkable expansion
and binding signal increase representing close to ∼30,000
binding sites at this late time point (Supplemental Fig.
EGR2 governs M2 macrophage polarization
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Figure 2. The transcription factor EGR2 is a direct STAT6 target. (A) Genome browser view on the Egr2 locus. ChIP-seq results for P300,
H3K27ac, STAT6, and RNAPII (s2P [2-phosphoserine form]) is shown in control (CTRL) and IL-4 polarizedmacrophages. RNA-seq results
are also shown on the indicated IL-4 time course. Putative enhancers are highlighted (E1–E24) and their genome activity pattern is indi-
cated as determined in Figure 1. Red asterisks indicate enhancers for which enhancer RNA levels are measured in C. (B) RT-qPCR mea-
surements of the Egr2mRNA levels on the indicated time course from wild-type (WT) and Stat6−/− macrophages. The level of mRNA is
normalized to the expression of Ppia. Experiments were repeated five times, and significant changes between groups were calculated by
two-way analysis of variance (ANOVA). (C ) RT-qPCRmeasurements of enhancer RNA levels on four distant enhancers over the indicated
time course fromWT and Stat6−/− macrophages. Experiments were repeated five times and significant changes between groups were cal-
culated by two-way analysis of variance (ANOVA). (D) Western blot of EGR2 expression in wild-type and Egr2fl/flmacrophages in the pres-
ence or absence of IL-4. Experiments were repeated four times. One representative blot is shown with duplicate samples. Total protein
serves as a loading control. (E) Read distribution plot of STAT6 binding in the three induced genome activity pattern groups in control
and IL-4 polarized macrophage for the indicated periods of time in a 2 kb window around the P300 summits. RPKM (reads per kilobase
per million mapped reads) values are plotted. (F ), Read distribution plot of EGR2 binding in the three induced genome activity pattern
groups in control and IL-4 polarized macrophage for the indicated periods of time in a 2-kb window around the P300 summits. RPKM
(reads per kilobase per million mapped reads) values are plotted. (G) Stacked bar plot representation of the cobinding properties of
STAT6 and EGR2 in the three regulatory element groups showing induced genome activity patterns.
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S2B,C). These results show that there is temporal separa-
tion between the STAT6 and EGR2 cistromes. Side by side
comparison of the STAT6 and EGR2 cistromes on the
genomic regions having differential genome activities
documented on Figure 1 also indicated strong spatial sep-
aration. Characteristically, STAT6 occupied sites with
“early transient,” while EGR2 exhibited stronger binding
signals at “early sustained” and “late” genome activity
sites with very little overlap (Fig. 2E–G). The genomic re-
gions bound by both factors belonged to “early sustained”
genome activity regions, but even there, binding was tem-
porally separated (Fig. 2E–G). These results clearly show
that there is spatial and temporal separation between
the TF cistromes, indicating the existence of an EGR2
dominated, late polarization program and making it un-
likely that EGR2 acts as a collaborator factor of STAT6.
The IL-4/STAT6/EGR2 axis is required to regulate gene
expression in alternatively polarized MFs
In order to probewhether the IL-4/STAT6/EGR2 axis is in-
deed functional in MFs, we performed a side-by-side com-
parison usingMFs differentiated from the bonemarrow of
Stat6−/− (full-body knockout) and Egr2-deficient (LysM-
Cre Egr2fl/fl [conditional knockout, referred to as Egr2fl/
fl])mice.WeshowthatEgr2fl/flMFsaredevoid ofEgr2 (Sup-
plemental Fig. S3A). Furthermore, neither Stat6−/− nor
Egr2fl/flMFsweredifferent fromwild type regarding the ex-
pression of MF cell surface markers (ADGRE1: F4/80 and
macrophage mannose receptor 1 [MRC1]) (Fig. 3C,F, con-
trol condition; Supplemental Fig. S3B–E) in the unstimu-
lated state, thus representing fully mature cells. After a
general characterization of the unstimulated MF state,
weassessed themRNAexpressionof a selected set of alter-
native polarization marker genes (Retnla, Ccl17, Chil3,
Chil4, Arg1, and Mrc1) using samples collected at six dif-
ferent timepoints (1, 3, 6, 12, and 24h) following IL-4 treat-
ment. In the absence of Stat6, all six genes had abrogated
response to IL-4 (Fig. 3A). Of these, Ccl17 showed total,
Retnla, Chil3, and Chil4 close to absolute dependence
on Egr2, while the induction of Arg1 and Mrc1 was inde-
pendent of Egr2 (Fig. 3B). Next, we chose one representa-
tive gene from each of these classes and determined
protein expression. Using flow cytometry, we studied the
protein expression of the phagocytic receptor MRC1 and
RETNLA (Resisitin-like molecule α) with roles in the res-
olution of inflammation as a secreted protein (Nair et al.
2009). Both MRC1 and RETNLA displayed IL-4/STAT6-
dependent expression (Fig. 3C–E). Loss of Egr2 did not af-
fect the expression of MRC1, but it was required for the
full induction of RETNLA (Fig. 3F–H). Enzyme-linked im-
munosorbent assay (ELISA) for the CC chemokine CCL17
with roles in autoimmune diseases (Saeki and Tamaki
2006) and pulmonary fibrosis (Belperio et al. 2004) secreted
by MFs exhibited an absolute dependence on both Stat6
and Egr2 (Fig. 3I,J). Thus, protein expressions followed
changes in mRNA levels in all three cases indicating
that MF function is likely to be substantially altered in
the absence ofEgr2. After establishing thatEgr2 is required
and necessary for many STAT6-regulated polarization-
specific changes we sought to examine whether Egr2 was
sufficient to bring about such changes.
Therefore, we performed gain-of-function experiments
onmyeloid cells differentiated from embryonic stem cells
harboring a doxycycline (DOX)-inducible minigene en-
coding Egr2 (Fig. 3K; Bencsik et al. 2016). DOX efficiently
induced the expression of EGR2, which was further aug-
mented in the presence of IL-4 (Fig. 3L). Overexpression
of Egr2 led to induced expression of Retnla and Chil3
even in the absence of IL-4. IL-4 exposure induced
the expression of all the measured genes (Egr2, Retnla,
Chil3, Chil4, and Ccl17), which was facilitated by the
overexpression of Egr2 (Fig. 3L). Therefore, Egr2 is neces-
sary and sufficient to induce the expression of at least a
select set of polarization specific marker genes. However,
this requirement has a range from none to substantial
to absolute, depending on the gene. Thus, we set out to
map the extent of this dependence in a genome-wide
fashion.
Loss of EGR2 severely impacts the transcriptome
of alternative polarization
In order to shed light on the extent of the Egr2-dependent
late polarization program, we performed RNA-seq experi-
ments in wild-type and Egr2fl/fl macrophages following 24
h of IL-4 polarization. Principal component analysis and
clustering of the samples based on Euclidean distance re-
ported good reproducibility, no impact on the unstimu-
lated MF state and the critical roles of IL-4 and EGR2 in
bringing about the alternative polarization program (Sup-
plemental Fig. S4A,B). Notably, members of the EGR fam-
ily (Egr1, Egr3, and Egr4) do not compensate for the loss of
Egr2 (Supplemental Fig. S4C). Global gene expression
analysis identified 845 induced and 1054 repressed genes
after 24 h of IL-4 treatment (Fig. 4A). Importantly, loss of
Egr2 affected 77% (649/845) of the induced and 64%
(676/1054) of the repressed gene program (n= 3; FDR
5%) (Fig. 4B; Supplemental Table S3). Of the 649 IL-4-
and EGR2-induced genes, 580 showed lower or abolished
sensitivity to IL-4, while 69 responded to a greater extent
upon cytokine treatment in the absence of Egr2. The de-
gree of repression also got diminished on 638 gene loci,
while 38 genes showed facilitated repression in the
Egr2−/− (Fig. 4C).
Assessing the effects of the loss of Stat6 or Egr2 on the
IL-4/EGR2-regulated gene programs revealed gene mod-
ules where the linkage of the two TFs can be appreciated
using RNA-seq. We observed the following gene modules
(all requiring STAT6) (Supplemental Fig. S4D): (1) IL-4/
STAT6-induced genes, where EGR2 negatively impacts
expression; (2) IL-4/STAT6/EGR2-induced genes; (3) IL-
4/STAT6/EGR2-repressed genes; (4) IL-4/STAT6-re-
pressed genes, where EGR2 has restraining activity on re-
pression; (5) IL-4/STAT6-induced genes without EGR2-
dependent regulation; and (6) IL-4/STAT6-repressed genes
that lack EGR2 dependence. This analysis underlines the
significant linkage between IL-4/STAT6 and EGR2, but
also establishes that STAT6 is not entirely dependent on
EGR2 to induce the late program.
EGR2 governs M2 macrophage polarization
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Figure 3. Both STAT6 and EGR2 are required to regulate gene expression during alternativemacrophage polarization. (A) RT-qPCRmea-
surements on the indicated marker genes of alternative macrophage polarization fromWT and Stat6−/− macrophages over the indicated
time course of IL-4 treatment. The level of mRNA is normalized to the expression of Ppia. Experiments were repeated five times, and
significant changes between groups were calculated by two-way analysis of variance (ANOVA). (B) RT-qPCRmeasurements on the indi-
catedmarker genes of alternativemacrophage polarization fromWTand Egr2fl/flmacrophages over the indicated time course of IL-4 treat-
ment. The level of mRNA is normalized to the expression of Ppia. Experiments were repeated five times, and significant changes between
groups were calculated by two-way analysis of variance (ANOVA). (C ) Representative FACS plot of MRC1 (CD206) and ADGRE1 (F4/80)
expression in control and IL-4 polarized macrophages from WT and Stat6−/− animals. (D) Representative FACS plot of RETNLA and
ADGRE1 (F4/80) expression in control and IL-4 polarized macrophages from WT and Stat6−/− macrophages. (E) Percentages of MRC1
(CD206), ADGRE1 (F4/80) and RETNLA, ADGRE1 (F4/80) double-positive macrophages in control and IL-4 treated conditions from
WT and Stat6−/− macrophages. Experiments were repeated three times, and significant changes between groups were calculated by
two-way analysis of variance (ANOVA). (F ) Representative FACS plot of MRC1 (CD206) and ADGRE1 (F4/80) expression in control
and IL-4 polarizedmacrophages from Egr2+/+ and Egr2fl/fl animals. (G) Representative FACS plot of RETNLA and ADGRE1 (F4/80) expres-
sion in control and IL-4 polarizedmacrophages from Egr2+/+ and Egr2fl/fl animals. (H) Percentages ofMRC1 (CD206), ADGRE1 (F4/80) and
RETNLA, ADGRE1 (F4/80) double-positive macrophages in control and IL-4 treated conditions from Egr2+/+ and Egr2fl/fl animals. Exper-
iments were repeated three times, and significant changes between groups were calculated by two-way analysis of variance (ANOVA). (I,J)
CCL17 levels determined by ELISA in control and IL-4-polarized WT, Stat6−/− and Egr2+/+, Egr2fl/fl macrophages. Experiments were per-
formed three times for the Stat6−/−, while four times for the Egr2fl/fl conditions, and significant changes were identified by two-way anal-
ysis of variance (ANOVA). (K ) Experimental scheme of the gain of function experiments using embryonic stem cells (ES) differentiated
towards the myeloid lineage in coculture with OP9 stromal cells, in the presence of GM-CSF. Doxycycline (DOX) was used to induce
Egr2 levels at the indicated time before IL-4 treatment (24-h exposure). Cells were harvested for gene expression analysis at day 11. (L)
RT-qPCRmeasurements of the indicated genes fromembryonic cell differentiatedmyeloid cells harboring a doxycycline (DOX)-inducible
EGR2 expressing construct. Cells were polarized with IL-4 (24 h) or left untreated (control). The level of mRNA is normalized to the ex-
pression of Ppia. Experiments were repeated five times and significant changes were identified by unpaired t-test at P <0.05.


















































































































































































































































































Figure 4. EGR2 controls alternative macrophage polarization. (A) Volcano plot of IL-4-induced and -repressed genes in wild-type (WT)
macrophages. (B) Stacked bar plot showing the percentages of the IL-4/Egr2-dependent and -independent induced and repressed genes.
(C ) Heat map representation of IL-4 altered, Egr2-dependent gene expression. IL-4-induced (left) and IL-4-repressed (right) gene expression
is visualized in Egr2+/+ and Egr2fl/fl macrophages. (D) Classification of IL-4-induced and Egr2-dependent genes based on the annotated
number of regulatory regions exhibiting early sustained or late genome activity patterns. Gene counts for each bar are represented and
the circles below indicate the presence or absence of annotated regulatory elements from the genome activity groups. Percentage-wise
distribution of the IL-4/Egr2-dependent genes with enhancer regions of the indicated genome activity patterns (stacked bar plot at the
right). (E) Regulatory regions showing early sustained and late genome activity patterns are annotated to IL-4/Egr2-induced genes. The
number of regulatory elements (enhancer count) annotated to the genes is shown. Differences between distributions were determined
by Kolmogorov–Smirnoff test. (F ) Read distribution plot of P300 ChIP-seq signal at EGR2 (+) and EGR2 (−) regions from Egr2+/+ and
Egr2fl/fl macrophages in the absence (control) and presence of IL-4 (24 h). (G) Read distribution plot of EGR2 ChIP-seq signal at regulatory
regions showing significant increment in P300 binding around IL-4/Egr2-induced genes. Regions of high EGR2-binding intensity [EGR2
(+)] andwith negligible binding [EGR2 (−)] are annotated to the target genes based on genomic proximity. RPKMvalues are plotted. (H) Box
plot representation of the average binding intensity of P300 ChIP-seq from the same conditions as presented in F. Log2 transformed CPM
(counts per million) values are depicted. Significant changes are determined with Wilcoxon test at P<0.05. (I ) Box plot representation of
the average binding intensity of EGR2 at EGR2 (+) and EGR2 (−) regions. Log2 transformed CPM (counts per million) values are depicted.
Significant changes are determined with Wilcoxon test at P <0.05.
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Next, we turned our attention to the putative regulatory
regions around the IL-4 and EGR2-induced genes display-
ing distinct genome activity patterns. Significantly, the
majority of the EGR2-induced genes had regulatory ele-
ments (±100 kb around the transcription start site) exhib-
iting “early sustained,” “late,” or both of these in these
genome activities (448/580) in agreement with the pro-
posed late and broad stabilizing roles of EGR2. We could
not assign such regulatory regions to 132 genes and 55
genes had regulatory elements bearing “early sustained”
genome activity (Fig. 4D). The number of regulatory re-
gions annotated to IL-4 and EGR2-induced genes showed
that the largest gene set possessed only one regulatory el-
ement, and these had a bias towards having “early sus-
tained” genome activity. Similar number of genes could
be linked to two regulatory regions associating with
slightly more genomic regions of “late” genome activity.
This latter trend was, in general, true for all of the genes
that had more than two annotated enhancers (Fig. 4E).
Thus, transcriptome analysis revealed the very large ex-
tentEGR2 is required for the IL-4 initiated late and stable al-
ternative MF polarization program. Moreover, these genes
are associating with genomic regions of “early sustained”
and“late” genomeactivities strongly suggesting that theef-
fect of EGR2 on polarization-specific gene regulation is di-
rect. Therefore, we next wanted to identify the molecular
mechanisms by which EGR2 impacts gene expression.
EGR2 induces epigenomic remodeling by direct and
indirect means
Identification of the geneswith IL-4/STAT6 and EGR2-de-
pendent induction allowed us to take a closer look at the
epigenetic state of the surrounding regulatory regions. For
these analyses, we used 580 genes showing reduced IL-4-
induced expression in Egr2−/− MFs. We annotated 1065
regulatory regions falling into a ±100-kb genomic window
around the transcription start site of these genes and ex-
hibiting IL-4- and EGR2-dependent P300 recruitment
based on ChIP-seq data (Fig. 4F,H). Of these regions,
59% (632/1065) bound EGR2 (+), while 41% (433/1065)
showed negligible binding signal; thus, we designated
them EGR2 negative (−) (Fig. 4G,I). Importantly, EGR2
(+) sites were annotated to 356 EGR2-dependent genes in-
dicating direct regulatory roles, accounting for 54% of the
total EGR2-induced gene program. Regarding genomic lo-
calization, 95%of these genomic regions were distal sites,
while 5% were promoter proximal sites (Supplemental
Fig. S4E). EGR2 (+) genomic regions showed strong enrich-
ment for the EGR TF bindingmotif. STAT6 and AP-1 mo-
tifs were present to similar degrees under both EGR2 (+)
and (−) sites. In addition, EGR2 (−) sites showed enrich-
ment for the TF motif, MITF, which has been linked to
MF functions by physically interacting with the myeloid
LDTF, PU.1 (Supplemental Fig. S4F; Luchin et al. 2001).
This classification provided the basis of our analysis to ex-
amine the roles of EGR2 at these putative regulatory ele-
ments around EGR2-dependent genes.
Assessing the active enhancer mark H3K27ac reported
that both EGR2 (+) and (−) regions had elevated acetyla-
tion levels in an IL-4 and EGR2-dependent manner (Fig.
5A,B). These data implicate the binding of acetylated his-
tone reader proteins to facilitate transcriptional initiation
and elongation. Thus, we examined whether EGR2 was
required for the recruitment of the acetylated histone
reader, Bromodomain-containing protein 4 (BRD4) and
whether it correlated with the presence of the elongating
RNA polymerase II (RNAPII). BRD4 is required for the
phosphorylation of the C-terminal domain of RNAPII on
Ser-2 by recruiting the P-TEFb complex to favor transcrip-
tional elongation (RNAPII-pS2) (Jang et al. 2005). ChIP-seq
analyses for both BRD4 and RNAPII-pS2 showed IL-4-in-
duced enrichment at EGR2 (+) and (−) sites, where IL-4-
mediated recruitment was EGR2-dependent. (Fig. 5A,B).
To asses whether inhibition of BRD4 affects the IL-4 and
EGR2-dependent program, we applied the JQ-1 inhibitor,
which ablates the binding ability of BRD4 to acetylated
histones in the paradigm of alternative polarization. The
inhibitor was added in the last 12 h of the 24-h long IL-4
treatment paradigm in order to avoid the inhibition of
the early transcriptional events (Supplemental Fig. S5A).
We examined two representative genes (Itgax and Retnla)
where EGR2 is both required for IL-4-induced transcrip-
tion and also for the recruitment of P300, BRD4, and
RNAPII-pS2 (Fig. 5C; Supplemental Table S2). The genes
showed very low expression levels in the unstimulated
state, but IL-4 robustly induced transcription, which was
dampened by BRD4 inhibition (Fig. 5D). Similarly, we
confirmed these results in our gain of function model sys-
tem (Supplemental Fig. S5B) by showing that the exclu-
sively EGR2-mediated induction of Itgax and Retnla
was impaired upon BRD4 inhibition (Fig. 5E), while it
does not have a negative effect on DOX-induced EGR2 ex-
pression (Supplemental Fig. S5C). Our results establish
the requirement for EGR2 in both the transcriptional
and epigenetic programming of IL-4 polarized MFs. How-
ever, it remained unclear whether EGR2 also contributed
to chromatin remodeling.
EGR2 is required for alternative polarization-induced
chromatin remodeling
To examine EGR2’s role in chromatin remodeling during
polarization,weassessed chromatin accessibility using as-
say for transposase-accessible chromatin sequencing
(ATAC-seq) (Buenrostro et al. 2013). Both EGR2 (+) and
EGR2 (−) genomic regions exhibited weak ATAC-seq sig-
nals in the unstimulated state, but IL-4 very substantially
induced accessibility. Polarization-induced chromatin
changes were abrogated in the absence of Egr2 (Fig. 5F,
G). In search of amechanism,wewerewonderingwhether
members of the SWI/SNF, ATP-dependent chromatin re-
modeling complex are also recruited to these regions and
exhibit similar dependencies. Thus, we assessed the ge-
nome-wide localization of Brahma (BRM or SMARCA2),
having key ATPase activities in the complex, changing
chromatin structure by altering the contacts of nucleo-
somes with DNA (Gatchalian et al. 2020). ChIP-seq un-
equivocally supported our hypothesis and showed IL-4
and EGR2-dependent chromatin binding of BRM at both
Daniel et al.
1482 GENES & DEVELOPMENT






















Figure 5. EGR2 establishes an enhancer network in the proximity of its target genes and remodels chromatin. (A) Read distribution plot
of H3K27ac, BRD4, and RNAPII-pS2 ChIP-seq signal at EGR2 (+) and EGR2 (−) regions from Egr2+/+ and Egr2fl/fl macrophages in the ab-
sence (control) and presence of IL-4 (24 h). (B) Box plot representation of the average binding intensities of H3K27ac, BRD4, and RNAPII-
pS2 ChIP-seq from the same conditions as presented in A. Log2 transformed CPM (counts per million) values are depicted. Significant
changes are determined by Wilcoxon test at P <0.05. (C ) Genome browser view on the Itgax and Retnla loci. ChIP-seq results for
EGR2 inwild-typemacrophages (Egr2+/+) and P300, BRD4, and RNAPII-pS2 in both Egr2+/+ and Egr2fl/flmacrophages are shown. Polarized
(24 h of IL-4 treatment) and control conditions are depicted for each protein. (D) RT-qPCRmeasurements of Itgax andRetnlamRNA levels
in JQ1 (BRD4 inhibitor) treated control and IL-4 polarizedmacrophages. Vehicle indicates solvent control for the JQ1 treatment. The level
of mRNA is normalized to the expression of Ppia. Experiments were repeated five times, and significant changes between groups were
calculated by, two-way analysis of variance (ANOVA). (E) RT-qPCRmeasurements of Itgax andRetnlamRNA levels in JQ1 (BRD4 inhib-
itor) treatedmyeloid cells possessing a doxycycline sensitive, EGR2 expressing construct. Experiments were performed in the absence (−)
and presence (+) of DOX. Vehicle indicates solvent control for the JQ1 treatment. The level of mRNA is normalized to the expression of
Ppia. Experiments were repeated five times, and significant changes between groups were calculated by two-way analysis of variance
(ANOVA). (F ) Read distribution plot of ATAC-seq signal at EGR2 (+) and EGR2 (−) regions from Egr2+/+ and Egr2fl/fl macrophages in
the absence (control) and presence of IL-4 (24 h). RPKM values are plotted. (G) Read distribution plot of BRM ChIP-seq signal at EGR2
(+) and EGR2 (−) regions from Egr2+/+ and Egr2fl/fl macrophages in the absence (control) and presence of IL-4 (24 h). (H) Box plot represen-
tation of the average signal intensity of ATAC-seq at EGR2 (+) and EGR2 (−) regions. Log2 transformed CPM (Counts Per Million) values
are depicted. Significant changes are determinedwithWilcoxon test atP <0.05. (I ) Box plot representation of the average signal intensity of
BRMChIP-seq at EGR2 (+) and EGR2 (−) regions. Log2 transformed CPM (counts per million) values are depicted. Significant changes are
determined with Wilcoxon test at P< 0.05.
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EGR2 (+) and EGR2 (−) sites (Fig. 5G,I), perfectly aligning
with our ATAC-seq results. Genes (Retnla and Itgax)
where EGR2 alone could induce gene expression in the
gain-of-function paradigm appeared to be very sensitive
to the loss of Egr2 and were unable to recruit BRM to their
promoters correlating with complete loss of promoter ac-
cessibility (Supplemental Fig. S5D).
These findings, along with the previously observed ef-
fects on genome activity patterns highlight the require-
ment for EGR2 during alternative polarization as a
mediator of transcriptional activation and chromatin re-
modeling, acting immediately downstream from STAT6.
The fact that there are similar changes at genomic regions
lacking EGR2 binding raised the possibility that these in-
direct effects are carried out by EGR2-induced TFs further
downstream, leading to the establishment of an at least
three-tiered transcriptional cascade.
EGR2 binds and activates enhancers on the Egr2 locus
indicative of autoregulation
We found so far that EGR2 is induced by the transiently
acting STAT6, but its cistrome remains stable, raising
the question of what maintains its expression at later
time points once STAT6 is gone? We took a closer look
at the putative enhancer regions of the Egr2 gene locus
and observed that EGR2 binds to at least five of these reg-
ulatory regions (E9: +96 kb, E13: +110 kb, E19: +159 kb,
E20: +165 kb), including one near its promoter (E1) (Fig.
6A). Moreover, all of these regulatory elements possess
strong EGR motifs. Looking at our ChIP-seq and ATAC-
seq results informed us about the IL-4 and EGR2-depen-
dent recruitment of P300, RNAPII, and BRM, while de
novochromatinopeningof theE13enhancer got abrogated
in the absence of EGR2 (Fig. 6B). As a proof of principle, we
selected two of these enhancers (E13 and E20) and
determined their transcriptional activities during the po-
larization time course. Enhancer RNA measurements
confirmed the presumed role of EGR2 in the induction of
both E13 and E20. Specifically, E13 exhibited late EGR2-
dependence (24 h), while E20 appeared to be EGR2 regulat-
ed at a very early (3-h) time point as well (Fig. 6C). Impor-
tantly, the earliest enhancer activities (1 h) were not
affected by the loss ofEgr2, in agreementwith the previous
findings that STAT6 initiates the expression of Egr2 (Fig.
6C).Thus, long-term,high expression level ofEgr2 is likely
to be at least in part,maintained byan autoregulatory feed-
back loop, where EGR2 occupies some of its own enhanc-
ers, sustaining its own expression and converting a
transient signal to a stable one.
EGR2 regulates the transcription factor cascade
of polarization
Next,we assessed the role of EGR2 in the regulation of the
downstream TF cascade of alternative polarization. We
used the TF database called TFcheckpoint consisting of
1020 TFs (Chawla et al. 2013). Overlaying this list with
all the expressed genes (n= 10,943) inmacrophages yielded
339 TFs. Of these, 173 showed IL-4 dependent regulation
and 76% (n= 132) were Egr2-dependent. Loss of Egr2 had
minimal enhancing effects on IL-4-mediated TF gene acti-
vation or repression (facilitated repressionn= 4, facilitated
activation n = 6), while it was required for IL-4-mediated
repression of 72 and activation of 50TF genes, respectively
(Supplemental Fig. S6A,B; Supplemental Table S4). Of the
IL-4-induced TFs, more have been reported as important
regulators of alternative polarization for instance Pparg,
Klf4,Myc, and Bhlhe40 but our analyses point to other po-
tential candidates, all downstream fromSTAT6 and EGR2
(Fig. 6D).
Next, as a proof of principle and to establish the hierar-
chical relationship between STAT6, EGR2, and a special-
ized downstream TF, we focused on PPARG due to its
roles in themaintenance of alternativemacrophage polar-
ization and lipid ligand-induced gene expression and the
fact that it was believed to be regulated by STAT6 (Lavin
et al. 2014; Dai et al. 2017; Murray 2017). On the Pparg
gene locus, EGR2 binds to several putative enhancers, re-
cruiting P300, BRD4, and RNAPII (Fig. 6E). Gene expres-
sion measurements validated the absolute IL-4/STAT6
and EGR2-dependent regulation of Pparg (Fig. 6F,G). In ad-
dition, protein expression of PPARG was also entirely
Stat6- and Egr2-dependent in the presence of IL-4 (Fig.
6H,I; Supplemental Fig. S6C,D). Moreover, IL-4 facilitated
ligand-induced transcription on some of the canonical
PPARG target genes (Angptl4, Cbfa2t3, Fabp4, and
Plin2) (Daniel et al. 2018b) in an EGR2-dependentmanner
(Fig. 6J). These results lend strong support to the notion
that EGR2 acts immediately downstream from STAT6
and acts upstream of a large number of TFs establishing
at least three layers of regulation or an evenmore complex
TF cascade of alternative macrophage polarization.
The IL-4/STAT6-induced Egr2 axis is evolutionarily
conserved in mouse and human macrophages
EGR2 appears to be a critical regulator of IL-4-induced po-
larization of murine macrophages. However, alternative
polarization is quite divergent between mice and humans
(Noël et al. 2004). Thus, we decided to assess whether IL-4
is able to induce EGR2 in human CD14+ monocyte-de-
rived differentiating macrophages (Supplemental Fig.
S7A). First, we examined the mouse and human Egr2
gene loci that exhibited considerable conservation as re-
vealed by phastCons tracks between the two species
(Fig. 7A). Second,we carried out extensive gene expression
measurements in the two species. For these experiments,
we also included the other major Th2 cytokine IL-13,
which robustly induces Egr2 expression in BMDMs (Sup-
plemental Fig. S7B). Humanmacrophages showed similar-
ly robust and sustained EGR2 expression upon either IL-4
or IL-13 exposure (Fig. 7B; Supplemental Fig. S7C). More-
over, we observed conservation between some of the dis-
tant regulatory regions of the mouse and human Egr2
loci. One of these enhancers that is located +76 kb from
the human EGR2 gene exhibited strong IL-4-induced en-
hancer RNA expression (Fig. 7C). Next, we used a specific
STAT6 inhibitor (AS1517499) as a pharmacological loss-
of-function tool to assess the roles of STAT6 in IL-4-
Daniel et al.
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Figure 6. The IL-4/STAT6/EGR2 axis controls the transcription factor cascade of alternative macrophage polarization. (A) Genome
browser view on the Egr2 locus. Shown are EGR2 ChIP-seq results in unstimulated (CTRL) and IL-4 polarized macrophages. Motif scores
of the EGRmotifs overlapping with putative enhancer elements are indicated. Asterisks indicate EGR2 bound regions magnified in B. (B)
Genome browser images on the enhancer regions highlighted inA. Shown are ChIP-seq results for EGR2, P300, RNAPII(s2P), and BRM in
Egr2+/+ and Egr2fl/fl macrophages in the absence (control) and presence of IL-4 (24 h). ATAC-seq results in the same conditions are also
shown. (C ) Enhancer RNA expression detected by RT-qPCR on the indicated loci. The level of eRNA is normalized to the expression
of Ppia. Experiments were repeated five times, and significant changes between groups were calculated by two-way analysis of variance
(ANOVA). (D) Heat map representation of IL-4 altered (induced and repressed), Egr2-dependent (top) and Stat6-dependent (bottom) tran-
scription factor gene expression. IL-4-induced (left) and IL-4-repressed (right) gene expression is visualized in the two genotypes. (E) Ge-
nome browser view on the Pparg gene locus. ChIP-seq data for EGR2 inwild typemacrophages (Egr2+/+) and P300, RNAPII(s2P) and BRD4
in both Egr2+/+ and Egr2fl/fl macrophages are shown. Polarized (24 h of IL-4 treatment) and control conditions are depicted for each track.
Regulatory regionswith STAT6 and EGRmotifs are highlighted. (F ) RT-qPCRmeasurements of PpargmRNAlevels inwild-type (WT) and
Stat6−/− control and IL-4 polarized macrophages over the indicated time course. The level of mRNA is normalized to the expression of
Ppia. Experiments were repeated five times, and significant changes between groups were calculated by two-way analysis of variance
(ANOVA). (G) RT-qPCRmeasurements of PpargmRNA levels in Egr2+/+ and Egr2fl/f control and IL-4 polarized macrophages over the in-
dicated time course. The level of mRNA is normalized to the expression of Ppia. Experiments were repeated five times, and significant
changes between groups were calculated by two-way analysis of variance (ANOVA). (H) Western blot of PPARG expression in wild-type
(Stat6+/+) and Stat6−/− macrophages in the presence or absence of IL-4. Experiments were repeated four times. One representative blot is
shown. GAPDH serves as a loading control. (I ) Western blot of PPARG expression in Egr2+/+ and Egr2fl/f macrophages in the presence or
absence of IL-4. Experiments were repeated four times. One representative blot is shown. GAPDH serves as a loading control. (J) RT-qPCR
measurements ofAngptl4,Cbfa2t3, Fabp4, and Plin2mRNA levels in Egr2+/+ andEgr2fl/fl control and IL-4 polarizedmacrophages exposed
to either solvent control (vehicle) or rosiglitazone (RSG). The level of mRNA is normalized to the expression of Ppia. Experiments were
repeated five times, and significant changes between groups were calculated by, two-way analysis of variance (ANOVA).
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induced EGR2 expression in human MFs. We found that
inhibition of STAT6 completely abolished the transcrip-
tion of both the EGR2 gene and the +76-kb enhancer,
thus the regulation of EGR2 by IL-4-activated STAT6 ap-
pears to be conserved between mouse and human MFs
(Fig. 7D,E). These results strongly positioned EGR2 as an
evolutionarily conserved mediator of STAT6-dependent
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Figure 7. The IL-4/STAT6 signaling axis
regulates EGR2 expression in human mono-
cytes and EGR2 expression marks lung-resi-
dent macrophage subsets. (A) Genome
browser views on the Egr2 loci in mouse
and human macrophages. Shown are RNA-
seq and STAT6 ChIP-seq results from the
two species. Annotated enhancers are high-
lighted and color-coded according to their ac-
tivity patterns. Conservation scores of the
Egr2 locus is presented in the phastCons
track followed by the liftOver track that
shows the annotation of the conserved
mouse enhancer regions to the human ge-
nome. The enhancer located +76 kb from
the human EGR2 gene is marked with an as-
terisk because it is conserved between the
two species and binds STAT6 as well. (B)
RT-qPCR measurements of EGR2 mRNA
levels in control and IL-4 polarized human
differentiatingmacrophages over the indicat-
ed time course. The level of mRNA is nor-
malized to the expression of PPIA.
Experiments were repeated four times, and
significant changes between groupswere cal-
culated by two-way analysis of variance
(ANOVA). (C ) RT-qPCR measurements of
the synthesized enhancer RNA levels from
the conserved enhancer located +76 kb from
the human EGR2 gene. The level of eRNA
fromcontrol and IL-4 polarizedhumandiffer-
entiating macrophages over the indicated
time course is shown, normalized to the ex-
pression of PPIA. Experiments were repeated
four times, and significant changes between
groups were calculated by two-way analysis
of variance (ANOVA). (D) RT-qPCR mea-
surements of EGR2 mRNA levels in control
and IL-4 polarized human differentiating
macrophages in the presence or absence
(DMSO [dimethyl sulfoxide as vehicle con-
trol]) of the STAT6 inhibitor (AS1517499) at
the two indicated time points. The level of
mRNA is normalized to the expression of PPIA. Experiments were repeated four times, and significant changes between groups were cal-
culated by two-way analysis of variance (ANOVA). (E) RT-qPCRmeasurements of enhancer RNA levels, synthesized from the +76-kb en-
hancer in control and IL-4 polarized human differentiating macrophages. Experiments were performed in the presence or absence (DMSO
[dimethyl sulfoxide as vehicle control]) of the STAT6 inhibitor (AS1517499) at the two indicated time points. The level of eRNA is normal-
ized to the expression of PPIA. Experimentswere repeated four times, and significant changes between groupswere calculated by two-way
analysis of variance (ANOVA). (F ) Heat map representation of the mRNA expression levels (RNA-seq GSE63340) of the EGR TF family
members in the indicated cell types. Egr4 transcript was not detected (n.d.) in any of the cell types. (G) UMAP depicting the different
cell clusters of themouse lung defined by single cell RNA-seq (GSE133747). Cluster 3 is highlighted,which corresponds to themacrophage
cluster having highCd68 andMrc1 expression. (H) Feature plots depicting the expression ofCd68,Mrc1, and Egr2 expression in themouse
data set. Cluster 3 is encircled to highlight themacrophage population. Log normalized expression values are plotted. (I ) Dot plot represen-
tation of the average expression and percentagewise expression ofCd68,Mrc1, and Egr2 in the different cell clusters of themouse data set.
(J)UMAPdepicting thedifferent cell clusters of thehuman lungdefinedbysingle cell RNA-seq (GSE128033).Clusters 0 and4arehighlight-
ed, which corresponds to the macrophage clusters having high CD68 andMRC1 expression. (K ) Feature plots depicting the expression of
CD68, MRC1, and EGR2 expression in the human data set. Clusters 0 and 4 are encircled to highlight the macrophage populations. Log
normalized expression values are plotted. (L) Dot plot representation of the average expression and percentage wise expression of CD68,
MRC1, and EGR2 in the different cell clusters of the human data set.
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but left us with a question regarding its role in vivo in tis-
sue MFs.
Egr2 expression marks lung-resident MF subsets in
different species
We sought to answer this question by analyzing published
RNA-seq data sets (GSE63340) from mouse monocytes
and various tissue resident MF subsets to obtain informa-
tion on the tissue-specific expression of Egr TF genes
(Lavin et al. 2014). It appears that most Egr TF genes
were widely expressed in tissue-specific MF subsets, but
Egr2 had a narrower expression pattern thatwas largely re-
stricted to alveolar MFs. Moreover, other EGR family
members were barely or not expressed in this MF subset,
suggesting amore specific role for EGR2 in these cells (Fig.
7F). This observation raised another question concerning
the evolutionarily conserved expression of Egr2 in the
lung-resident MF subsets of other species.
Single-cell RNA-seq data sets from mouse, human, pig,
and rat healthy lungs were used from recently published
work to address this question (Morse et al. 2019; Raredon
et al. 2019). We analyzed these data and performed uni-
form manifold approximation and projection for dimen-
sionality reduction (UMAP) (Becht et al. 2018) using all
of the cells from the different species (Fig. 7G,J; Supple-
mental Fig. S7D,G). Regarding the human lung analyses,
we integrated data sets from five healthy lung samples
from the following study (GSE128033) (Supplemental
Fig. S7J;Morse et al. 2019),while lung data sets of the other
species are derived fromGSE133747 (Raredon et al. 2019).
After dimensionality reduction, we called clusters and
identified MFs based onCd68,Mrc1 (mouse: cluster3, hu-
man: clusters 0 and 4, and rat: cluster 2), orCD163,MRC1
(pig: cluster 7) expression (Fig. 7H,I,K,L). After the identifi-
cation of the MF clusters, we plotted the expression of
EGR2, which was specific to at least onemacrophage pop-
ulation in the different species (Fig. 7H,I,K,L; Supplemen-
tal Fig. S7E,F,H,I). Importantly, high EGR2 expression
appeared to be relatively specific to the MF compartment
in all the studied species. Thus, besides being required
for IL-4/STAT6-induced polarization in murine MFs,
EGR2’s induction by STAT6 appears to be evolutionarily
conserved between mouse and human MFs. In addition,
bulk and single-cell RNA-seq data point to EGR2 as a reg-
ulator of lung-resident MF function in the steady state,
which should be investigated in future studies.
Discussion
Understanding the hierarchical transcriptional programof
MF polarization in health and disease will ultimately lead
to a better knowledge of cell type specification and target-
ed therapies, aiming to reprogram MFs to exploit benefi-
cial phenotypes and to avoid harmful ones. Here, we
identified the zinc finger TF, EGR2 as an essential compo-
nent of the IL-4-mediated and STAT6-dependent alterna-
tive polarization program linking the early transient
events to late, stable ones establishing key hierarchical re-
lationships between layers of TFs.
Here we show that (1) EGR2 is an evolutionarily con-
served direct target of STAT6 in murine and human MFs;
(2) EGR2 and STAT6 establish temporally and spatially dis-
tinct cistromes during polarization; (3) around three-quar-
ters (77%) of STAT6-regulated genes depend on the
presence of EGR2; (4) EGR2 is sufficient to directly regulate
target genes as well as recruit chromatin remodeling and
histone-modifying complexes, including an autoregulatory
loop inducing itsownexpression; (5) EGR2controls adown-
stream TF cascade of process-specific TFs, including
PPARG, and thusworks as amolecular linchpin to connect
the transient STAT6 signal to long-lasting epigenomic
changes to support stable gene expression; and (6) EGR2
marks lung-resident macrophage subsets in multiple spe-
cies.The importanceofSTAT6downstreamregulators, act-
ing when STAT6 is excluded from the nucleus, has been
raised by prior research in the establishment and mainte-
nance of the late polarization program (Murray 2017).How-
ever, so far, no broad acting transcriptional and/or
epigenomic mechanism was identified to explain this co-
nundrumand establish the sequence of events.We took ad-
vantage of mapping the genome activity (using the active
enhancer markers P300 and H3K27ac) patterns of macro-
phage polarization over a time course, where both the im-
mediate early and long-term (likely indirect) effects of IL-
4-activated STAT6 can be studied. This strategy proved to
be fruitful and led to the identification of a singular very po-
tent transcriptional regulator,EGR2with thus farunknown
function in myeloid cells. Although transcriptome-wide
analyses reported Egr2 as an IL-4-induced gene in macro-
phages, it remained hidden in the vast data sets without
any detail about the nature and extent of its roles (Jablonski
et al. 2015; Roy et al. 2015). More recently, EGR2 has been
linked to the induction of a fewmarker genes of alternative
polarization but neither its genome-wide contribution to
the epigenomic and transcriptomic program, nor its mech-
anism of action was revealed in great detail (Veremeyko
et al. 2018).
The EGR TF family members possess a highly homolo-
gous DNA-binding domain, thus recognize the same
DNA sequence, implying the potentially overlapping or
redundant roles of the family members (Poirier et al.
2007). In our model, Egr genes are not or barely expressed
in unstimulated macrophages. IL-4 selectively induce
Egr2, and no other members of the family are responsive
to IL-4. Moreover, the genetic deletion of Egr2 does not af-
fect the expression of the other Egr genes; thus, there is no
redundancy and other EGRs do not compensate for the
loss of Egr2. This is a key feature of our study because it
allowed the thorough characterization of EGR2’s role
without other family members’ interference. EGR2 was
found to be dispensable for macrophage differentiation
(Carter and Tourtellotte 2007), and our results confirm
these findings by showing that the lack of Egr2 does not
impact the unstimulated MF phenotype, and therefore
EGR2 is not needed for MF differentiation per se. Howev-
er, EGR family members are primarily linked to memory
formation and learning in the central nervous system
(CNS) (Poirier et al. 2007), several studies reveal their crit-
ical roles in the immune system (Schneider et al. 2014),
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including T cells, suggesting that they have roles in estab-
lishing transcriptional programs beyond the CNS. Our
study is supporting this notion and establishes EGR2 as
an essential regulator of MF polarization with the role to
imprint the long-term epigenetic and transcriptomic pro-
gram of IL-4.
In terms of its precise participationwithin the sequence
of events in alternative polarization program, Egr2 is
turned on by IL-4-activated STAT6 during the first hour
of cytokine exposure. This immediate early response
and induction allows EGR2 to take the baton from
STAT6, which is being released from the chromatin by
the time EGR2 populates the MF genome. The cistromic
behavior of STAT6 and EGR2 are rather different and al-
most mutually exclusive, displaying remarkable spatial
and temporal separation. Therefore, EGR2 connects the
early STAT6-driven gene expression program to the late
mostly EGR2-driven program. Importantly, these data im-
ply that mechanistically EGR2 is neither a cofactor, nor a
collaborator factor of STAT6. Regarding the impact of
EGR2 on polarization we could show that besides the ca-
nonical alternative polarization marker genes (Retnla,
Chil3, Chil4, and Mmp12), EGR2 controls 77% of the
late gene expression program of polarization, including
TFs (Klf4, Myc, Pparg, and Bhlhe40) with already de-
scribed downstream roles indicating its broad impact. As
a proof of principle, we show that the nuclear receptor
PPARG is one of these TFs, which has been linked to alter-
native polarization and is vital for alveolar MF develop-
ment (Odegaard et al. 2007; Schneider et al. 2014). We
reported previously that IL-4-activated STAT6 facilitates
ligand responses of PPARG by increasing the level and
chromatin binding of the protein (Szanto et al. 2010; Dan-
iel et al. 2018a). Here we extend this model with a critical
new piece by showing that in the absence of EGR2, IL-4-
activated STAT6 is no longer able to induce the expres-
sion of PPARG. Thus, EGR2 is immediately downstream
from STAT6 and indispensable for the augmented ligand
responsiveness of PPARG by regulating the receptor’s ex-
pression. Moreover, EGR2 binds and regulates its own en-
hancers’ activities indicative of autoregulatory role,
which might be important in carrying out its broad,
long-term effects and converting a transient STAT6 signal
to a permanent, sustained epigenomic imprint (Fig. 8).
Therefore, EGR2 is not part of the transcriptionalmachin-
ery regulating STAT6-dependent target genes. Instead, it
is a strictly downstream epigenomic effector. This reveals
an at least three-tiered transcriptional cascade with IL-4-
regulated STAT6 on top turning on hundreds of genes, a
fraction of them independent of EGR2. Then, EGR2 as a
“transcriptional second messenger” is robustly induced,
regulates its own expression, and can provide stable epige-
nomic changes along with the induction of TFs with
much narrower specificity such as PPARG, KLF4, or
BHLHE40. It is possible that additional levels of regula-
tion exist and that the process gets “lateral input” from
additional signaling pathways. Transcriptional cascades
have been identified in classical polarization using LPS
signaling as a model (Tong et al. 2016). However, in that
case, no broad-acting secondary TF has been identified,
but rather several members of the NFkB family have
unique and also overlapping roles. EGR2 acquires this
central and broad role by a multitude of regulatory activi-
ties: (1) chromatin remodeling and recruitment of the
ATP-dependent chromatin remodeling complex (SWI/
SNF)member BRM (SMARCA2), (2) de novo enhancer for-
mation and recruitment of the acetyltransferase P300 to
deposit H3K27ac on enhancers, and (3) probably as a con-
sequence of the previous two, EGR2 attracts BRD4 and fa-
cilitates transcriptional elongation (Fig. 8). The exact
order and molecular details, including the contribution
of the specific domains of EGR2, need to be uncovered
in future studies.
The IL-4/STAT6/EGR2 axis is conserved between mice
and humans and the expression of EGR2 can be induced
by bothTh2-type cytokines (IL-4 and IL-13) in both species.
Thus, EGR2belongs to theotherwise remarkably lownum-
ber of alternative polarization-specificmarker genes shared
by these two species such as Mrc1, Arg1, and fibronectin
(Fn1) (Noël et al. 2004), adding to its presumed significance.
In terms of tissue-specific activity and relevance, alterna-
tive MF polarization has been observed in a variety of dis-
ease conditions like allergic airway disease (Gour and
Wills-Karp 2015), helminth infection, fibrosis, and cancer
Figure 8. The role of Egr2 in the transcriptional cascademediat-
ing IL4/STAT6-induced alternative polarization. The Th2-type
cytokine IL-4 induces the phenotypic switch of macrophages to
become alternatively polarized (top). The immediate early tran-
scriptional regulator of alternative polarization STAT6 orches-
trates a rapidly developing but transient gene expression
program including the marker genes of polarization (Mrc1 and
Arg1). The transcription factor EGR2 is also subject to IL-4/
STAT6-mediated early induction via enhancer activation
(H3K27ac) and RNAPII recruitment (middle panel). Once the po-
larization program proceeds to the late stages, EGR2 becomes a
central component by guiding the transition between early and
late polarization, acting as a “molecular linchpin” via forming
an extensive cistrome and chromatin remodeling activity. EGR2
regulates thevastmajorityof the latepolarizationprogram includ-
ing the signature genes of this stage (Retnla, Ccl17, and Itgax).
Moreover, EGR2controls the expression of an entire transcription
factor cascade including PPARG, BHLHE40, and KLF4 with im-
portant roles in alternative macrophage polarization. This pro-
gram is sustained partly by EGR2’s autoregulatory activity.
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(VanDykenandLocksley 2013), therefore these are obvious
places and processes EGR2’s role could and should be stud-
ied in. Our efforts are hindered though by the facts that al-
ternative polarization is altered drastically by exposure to
other cytokines and signals, the lackof clear evidence to es-
tablish theroleofMF-specificSTAT6 in theseprocessesdue
to the unavailability of tissue-specific knockouts. In addi-
tion, redundancy, that is, the induction and compensatory
activity of other EGR family members cannot be easily ex-
cluded.Withoutabetterunderstandingof theroleofSTAT6
and the integration of other signals with it working out
EGR2’s role appears to be rather futile.Nonetheless, the re-
analysis of mouse tissue-resident macrophage RNA-seq
data revealed a lung-restricted expression pattern for Egr2
in the steady state. This along with the finding of baso-
phil-derived IL-13 playing a role in alveolar macrophage
function (Cohen et al. 2018) lend further support to
EGR2’s in vivo role. Further analysis of published single-
cell RNA-seq data frommouse, rat, pig, and humanhealthy
lung samplesnot only confirmed theexpressionofEgr2, but
also revealed the evolutionarily conserved presence of Egr2
in lung-resident macrophage populations. Therefore, work
canbe initiated todefine invivo rolesofEgr2 in the lung-res-
ident macrophage subsets. In summary, we discovered
EGR2, a molecular linchpin connecting the early and late
alternative polarization program, with broad specificity
and molecular functions inducing chromatin opening and
histone acetylation, representing an evolutionarily con-
served component of mouse and human MF responses to
Th2-type cytokine rich milieu.
Materials and methods
Mouse strains
Male,wild-type 3-mo-oldmicewere used and bred under specific-
pathogen-free (SPF) conditions. All the strains were kept on the
C57BL/6 genetic background. The Egr2fl/fl animals were a gener-
ous gift from Patrick Charnays laboratory. We crossed these ani-
mals with lysozyme-Cre (LysCre)+ animals to establish the
conditional knockout strain (Egr2fl/fl LysCre). These mice were
backcrossed to the C57BL/6J strain for eight generations. As con-
trols we used Egr2+/+ LysCre littermates. Full-body Stat6−/− (Jack-
son Laboratory) animals were maintained by breeding knockout
male and female mice. Wild-type C57BL/6 animals were used
as controls. Animals were handled according to the regulatory
standards of the animal facilities of the University of Debrecen
and Johns Hopkins All Children’s Hospital.
Bone marrow-derived macrophages
Isolation and differentiation were completed as described earlier
(Daniel et al. 2014b). Isolated bonemarrow-derived cells were dif-
ferentiated for 6 d in the presence of L929 supernatant. On the
third dayof differentiation, supernatantwas collected centrifuged
and replated into the same plates in fresh media and differentia-
tion continued for three more days.
Treatment conditions
For description regarding treatment conditions, see the Supple-
mental Material.
ChIP (chromatin immunoprecipitation)
ChIP was performed with minor modifications of the previously
described protocol (Daniel et al. 2014a). We lowered the sonica-
tion strength to low and shearing was performed in two consecu-
tive rounds of 5 min (total 10 min). Libraries were prepared with
Ovation Ultralow Library Systems V2 (Nugen) according to the
manufacturer’s instructions. The following antibodies were
used: EGR2 (sc-20690), P300 (sc-585), BRM (ab15597), BRD4
(A301-985A100), H3K27ac (ab4729), RNAPII-pS2 (ab5095).
RNA-seq
Wild-type and Egr2fl/fl macrophages were differentiated in the
presence of L929 cell supernatants for 6 d on 15-cm dishes. On
the sixth day cells were replated onto six-well plates at a 2 × 106
cells/mL density and treated with IL-4 (20 ng/mL) for 24 h or
left untreated. After 24 h, RNA was collected and isolated with
Trizol. For additional details regarding RNA-seq, see the Supple-
mental Material.
Western blot
Whole-cell lysates were resolved by electrophoresis in 10% poly-
acrylamide gel and then transferred to immobilon-P transfer
membrane. Membranes were probed with anti-PPARγ (81B8)
anti-Egr2 (ab108399) and anti-GAPDH (AM4300) antibodies as
indicated according to manufacturer’s recommendations.
Monocyte isolation and differentiation
Humanmonocytes were isolated from peripheral bloodmononu-
clear cells (PBMC) of healthy volunteers. Buffy coats were ob-
tained from the Regional Blood Bank. For additional details
regarding monocyte isolation and differentiation, see the Supple-
mental Material.
Real-time quantitative PCR for enhancer RNA and mRNA detection
(qPCR)
RNA was isolated with Trizol reagent (Ambion). RNA was re-
verse-transcribed with high-capacity cDNA reverse transcription
kit (Applied Biosystems) according to the manufacturer’s proto-
col. Transcript quantification was performed by qPCR reactions
using SYBR Green master mix (Roche). Transcript levels were
normalized to Ppia and PPIA. Primers are available upon request.
Generation of ES-derived myeloid progenitors
To generate chemically inducible ESC clones, a p2lox targeting
vector was engineered that carry the murine Egr2 coding se-
quence. The targeting vector was delivered into the ZX1 ESCs
for generation of doxycycline-inducible ESC clones as described.
For additional details regarding generation of ES-derived myeloid
progenitors, see the Supplemental Material.
ELISA
Culture supernatants from cells were collected at the indicated
times. Samples were centrifuged at 1000g for 10 min at 4°C,
and the supernatants were separated and stored at −20°C until
analysis. These supernatants were then probed for the presence
of the following cytokine using ELISA kits according to the man-
ufacturer’s instructions: thymus and activation-regulated chemo-
kine (CCL17/TARC; DuoSet ELISA DY529; R&D Systems).
Plates were read using the ThermoMultiskan Ascent microplate
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reader and analyte concentrations were calculated with Procarta-
Plex Analyst 1.0 software from Affymetrix.
Flow cytometry
For flow cytometricmeasurements, cells were labeledwith Zom-
bieGreen fixable viability dye (Biolegend) for 15min at room tem-
perature and then blocked with anti CD16/32 (2.4G2) in staining
buffer (1× PBS+ 2%FBS) for 15 min at 4°C. Cell surface staining
was performed in staining buffer to F4/80 (Biolegend BM8),
CD206 (AbD SerotecMR5D3) for 30min at 4°C. For intracellular
detection of RELMα, Zenon Alexa fluor 350 rabbit IgG labeling
kit (Thermo Fischer Scientific) was used to add fluorescent label
to RELMα (Peprotech) antibody, BD Cytofix Cytoperm fixation/
permeabilization solution kit (BD Biosciences) was used for fixa-
tion/permeabilization and staining according to the manufactur-
er’s recommendations. Sampleswere acquired on a BDFACSAria
III (BD Biosciences) cell sorter using BD FACSDiva 6.0 software
(BD Biosciences). Data analysis was performed using FlowJo v10
software (Becton Dickinson and Company).
ATAC-seq
ATAC-seq was carried out as described earlier with minor modi-
fication. For additional details regarding generation of ATAC-seq,
see the Supplemental Material.
RNA-seq mapping and gene expression quantification
Sequencing quality was evaluated by FastQC software (http
://www.bioinformatics.babraham.ac.uk/projects/fastqc). Reads
were aligned to the mouse reference genome (mm10) using the
default parameters ofHISAT2 (Kim et al. 2019). For additional de-
tails regarding RNA-seqmapping and gene expression quantifica-
tion, see the Supplemental Material. Differentially expressed
genes are reported in Supplemental Tables S3 and S4.
ATAC-seq and ChIP-seq analyses
Sequencing quality was evaluated by FastQC software. The pri-
mary analysis of ATAC-seq and ChIP-seq reads was carried out
using our ChIP-seq command line pipeline (Barta 2011). For addi-
tional details regarding ATAC-seq and ChIP-seq analyses, see the
Supplemental Material.
P300 differential binding analysis
To determine significant genome activity patterns, we first used
DiffBind (Ross-Innes et al. 2012) to generate a P300 consensus
peak sets with minOverlap = 2 to generate the raw count matrix
for these regions. Peaks with at least 10 CPM (counts per million)
in two samples were kept for the downstream analyses. For addi-
tional details regarding P300 differential binding analysis, see the
Supplemental Material.
De novo motif analysis and motif enrichment
We used HOMER’s findMotifsGenome.pl script to search for de
novo motif enrichments with mm10 -len 10,12,14 -size 200
-dumpFasta -bits -homer2 parameters. The resulting STAT6 and
EGR position weight matrices (PWMs) were used as an input
for annotatePeaks.pl (mm10 -size 500 -hist 10) to calculate motif
enrichment scores and histograms. Data were visualized in R
with ggplot2. Genomic positions of the motives were calculated
using scanMotifGenomeWide.pl with default parameters
(mm10).
Analyses of publicly available single-cell RNA-seq data
We used the following data sets: GSE133747 and GSE128033.
Analysis was performed using Seurat (version 3.1.2) (Stuart
et al. 2019). For additional details regarding P300 differential
binding analysis, see the Supplemental Material.
Statistical analysis
Statistical analyses were performed in R 3.6.2. qPCR measure-
ments were presented as means ± SD. We generated at least three
biological replicates. The exact replicate numbers are indicated in
the figure legends.Differences between groupswere calculated by
two-way analysis of variance [ANOVA; stats::aov() function] with
Tukey’s post hoc test [multcomp::glht() function] or Kolmogorov-
Smirnov test. Statistical significance is depicted as follows: P <
0.05 (∗), P <0.01 (∗∗), and P<0.001 (∗∗∗). ATAC-seq and ChIP-seq
densities presented on box plots were analyzed with Wilcoxon
test in R, using random resampling approach. Statistical parame-
ters are reported in the figure legends and also in themethods sec-
tion under each specific method description.
Data and software availability
Publicly available, published data sets can be accessed on the fol-
lowing GEO accession numbers: single-cell RNA-seq data sets
GSE133747 and GSE128033 and published bulk RNA-seq of tis-
sue-resident macrophage populations GSE63340. Sequencing
data sets performed in this study are available at the NCBI GEO
under accession number GSE151015.
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